The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Quantitative signal detection using spontaneous ADR reporting
Abstract
Quantitative methods are increasingly used to analyse spontaneous reports. We describe the core concepts behind the most common methods, the proportional reporting ratio (PRR), reporting odds ratio (ROR), information component (IC) and empirical Bayes geometric mean (EBGM). We discuss the role of Bayesian shrinkage in screening spontaneous reports, the importance of changes over time in screening the properties of the measures. Additionally we discuss three major areas of controversy and ongoing research: stratification, method evaluation and implementation. Finally we give some suggestions as to where emerging research is likely to lead. Copyright © 2009 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Under-Reporting of Adverse Drug Reactions: A Systematic Review
Hazell, L., & Shakir, S. A. W. (2006) · Drug Safety · doi:10.2165/00002018-200629050-00003 · Cited by 1,931
Evans, S. J. W., Waller, P. C., & Davis, S. (2001) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.677 · Cited by 1,802
Self-citationA Bayesian neural network method for adverse drug reaction signal generation
Bate, A., Lindquist, M., Edwards, I. R., Olsson, S., Orre, R., Lansner, A., & De Freitas, R. M. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050466 · Cited by 1,476
Self-citationvan Puijenbroek, E. P., Bate, A., Leufkens, H. G. M., Lindquist, M., Orre, R., & Egberts, A. C. G. (2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.668 · Cited by 1,372
Self-citationThe reporting odds ratio and its advantages over the proportional reporting ratio
Rothman, K. J., Lanes, S., & Sacks, S. T. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1001 · Cited by 1,111
Dumouchel, W. (1999) · The American Statistician · doi:10.1080/00031305.1999.10474456 · Cited by 878
Szarfman, A., Machado, S. G., & O??Neill, R. T. (2002) · Drug Safety · doi:10.2165/00002018-200225060-00001 · Cited by 700
Harmonisation in Pharmacovigilance
Edwards, I. R., & Biriell, C. (1994) · Drug Safety · doi:10.2165/00002018-199410020-00001 · Cited by 395
Sanz, E. J., De-las-Cuevas, C., Kiuru, A., Bate, A., & Edwards, R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17865-9 · Cited by 382
Self-citationEmpirical bayes screening for multi-item associations
DuMouchel, W., & Pregibon, D. (2001) · Proceedings of the seventh ACM SIGKDD international conference on Knowledge discovery and data mining · doi:10.1145/502512.502526 · Cited by 266
Wysowski, D. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02490-x · Cited by 240
Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study
Coulter, D. M., Bate, A., Meyboom, R. H. B., Lindquist, M., & Edwards, I. R. (2001) · BMJ · doi:10.1136/bmj.322.7296.1207 · Cited by 234
Self-citationLindquist, M., St??hl, M., Bate, A., Edwards, I. R., & Meyboom, R. H. B. (2000) · Drug Safety · doi:10.2165/00002018-200023060-00004 · Cited by 230
Self-citationNorén, G. N., Bate, A., Orre, R., & Edwards, I. R. (2006) · Statistics in Medicine · doi:10.1002/sim.2473 · Cited by 205
Self-citationA statistical methodology for drug–drug interaction surveillance
Norén, G. N., Sundberg, R., Bate, A., & Edwards, I. R. (2008) · Statistics in Medicine · doi:10.1002/sim.3247 · Cited by 199
Self-citationThe role of databases in drug postmarketing surveillance
Rodriguez, E. M., Staffa, J. A., & Graham, D. J. (2001) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.615 · Cited by 165
Practical pharmacovigilance analysis strategies
Gould, A. L. (2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.771 · Cited by 154
Duplicate detection in adverse drug reaction surveillance
Norén, G. N., Orre, R., Bate, A., & Edwards, I. R. (2007) · Data Mining and Knowledge Discovery · doi:10.1007/s10618-006-0052-8 · Cited by 144
Self-citationA model for the future conduct of pharmacovigilance
WALLER, P. C., & Evans, S. (2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.773 · Cited by 136
Self-citationvan der Heijden, P. G. M., van Puijenbroek, E., van Buuren, S., & van der Hofstede, J. W. (2002) · Statistics in Medicine · doi:10.1002/sim.1157 · Cited by 136
Moore, N., Kreft-Jaïs, C., Haramburu, F., Noblet, C., Andréjak, M., Ollagnier, M., & Bégaud, B. (1997) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1997.00615.x · Cited by 134
van Puijenbroek, E., Egberts, T. C. G., Heerdink, E. R., et al. (2000) · European Journal of Clinical Pharmacology · doi:10.1007/s002280000215 · Cited by 131
Brown, J. S., Kulldorff, M., Chan, K. A., Davis, R. L., Graham, D. J., Pettus, P. T., Andrade, S. E., Raebel, M. A., Herrinton, L. J., Roblin, D. W., et al. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1509 · Cited by 126
Risks of non-sedating antihistamines
Lindquist, M., & Edwards, I. R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)26018-6 · Cited by 125
Bayesian neural networks with confidence estimations applied to data mining
Orre, R., Lansner, A., Bate, A., et al. (2000) · Computational Statistics & Data Analysis · doi:10.1016/s0167-9473(99)00114-0 · Cited by 122
Self-citationQuality criteria for early signals of possible adverse drug reactions
Edwards, I. R., Lindquist, M., Wiholm, B. ‐., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)91669-2 · Cited by 119
Moore, N. D., Hall, G. C., Sturkenboom, M., Mann, R., Lagnaoui, R., & Bégaud, B. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.848 · Cited by 117
Tachycardia during cisapride treatment.
Olsson, S., & Edwards, I. R. (1992) · BMJ · doi:10.1136/bmj.305.6856.748-a · Cited by 109
Signal Selection and Follow-Up in Pharmacovigilance
Meyboom, R. H. B., Lindquist, M., Egberts, T. C. G., & Edwards, I. R. (2002) · Drug Safety · doi:10.2165/00002018-200225060-00011 · Cited by 105
Appraisal of the MedDRA Conceptual Structure for Describing and Grouping Adverse Drug Reactions
Cédric Bousquet, B., Lagier, G., Louët, A. L., Beller, C. L., Alain Venot, A., & Jaulent, M. (2005) · Drug Safety · doi:10.2165/00002018-200528010-00002 · Cited by 97
Roux, E., Thiessard, F., Fourrier, A., et al. (2005) · IEEE Transactions on Information Technology in Biomedicine · doi:10.1109/titb.2005.855566a · Cited by 87
Zhou, W., Pool, V., Destefano, F. R., Iskander, J. K., Haber, P., & Chen, R. T. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.998 · Cited by 86
Niu, M. T., Erwin, D., & Braun, M. M. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00237-7 · Cited by 85
From association to alert—a revised approach to international signal analysis
Lindquist, M., Edwards, I. R., Bate, A., Fucik, H., Nunes, A. M., & Ståhl, M. (1999) · Pharmacoepidemiology and Drug Safety · Cited by 79
Self-citationEffects of Coding Dictionary on Signal Generation
Brown, E. G. (2002) · Drug Safety · doi:10.2165/00002018-200225060-00009 · Cited by 77
Data Quality Management in Pharmacovigilance
Lindquist, M. (2004) · Drug Safety · doi:10.2165/00002018-200427120-00003 · Cited by 77
Determinants of signal selection in a spontaneous reporting system for adverse drug reactions
van Puijenbroek, E., van Grootheest, K., Diemont, W. L., Leufkens, H. G. M., & Egberts, T. C. G. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01501.x · Cited by 68
Ståhl, M., Lindquist, M., Edwards, I. R., et al. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.894 · Cited by 60
Safety Related Drug-Labelling Changes
Hauben, M., & Reich, L. (2004) · Drug Safety · doi:10.2165/00002018-200427100-00004 · Cited by 59
Impact of Stratification on Adverse Drug Reaction Surveillance
Hopstadius, J., Norén, G. N., Bate, A., & Edwards, I. R. (2008) · Drug Safety · doi:10.2165/00002018-200831110-00008 · Cited by 59
Self-citationEffects of Stratification on Data Mining in the US Vaccine Adverse Event Reporting System (VAERS)
Woo, E. J., Ball, R., Burwen, D. R., & Braun, M. M. (2008) · Drug Safety · doi:10.2165/00002018-200831080-00003 · Cited by 57
Stephens’ Detection of New Adverse Drug Reactions
Aronson, J. K. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02121.x · Cited by 54
Anaphylactic Reactions to Proton-Pump Inhibitors
Natsch, S., Vinks, M. H., Voogt, A. K., et al. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19235 · Cited by 54
Temporal pattern discovery for trends and transient effects
Norén, G. N., Bate, A., Hopstadius, J., Star, K., & Edwards, I. R. (2008) · ACM SIGKDD Conference on Knowledge Discovery and Data Mining (KDD) · doi:10.1145/1401890.1402005 · Cited by 47
Self-citationHauben, M., Reich, L., & Chung, S. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0834-0 · Cited by 43
Brown, J. S., Kulldorff, M., Petronis, K. R., Reynolds, R. F., Chan, K. A., Davis, R. L., Graham, D., Andrade, S. E., Raebel, M. A., Herrinton, L. J., et al. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1706 · Cited by 42
A statistical methodology for postmarketing surveillance of adverse drug reaction reports
Norwood, P. K., & Sampson, A. R. (1988) · Statistics in Medicine · doi:10.1002/sim.4780071004 · Cited by 41
Statistical Techniques for Signal Generation
Purcell, P. M., & Barty, S. (2002) · Drug Safety · doi:10.2165/00002018-200225060-00005 · Cited by 36
Orre, R., Bate, A., Norén, G. N., SWAHN, E., Arnborg, S., & Edwards, I. R. (2005) · International Journal of Neural Systems · doi:10.1142/s0129065705000219 · Cited by 35
Self-citationRolka, H. R., Bracy, D., Russell, C., Fram, D. M., & Ball, R. (2005) · Statistics in Medicine · doi:10.1002/sim.2035 · Cited by 25
Automated support for pharmacovigilance: a proposed system
Bright, R. A., & Nelson, R. C. (2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.684 · Cited by 22
Stratification for Spontaneous Report Databases
Evans, S. J. W. (2008) · Drug Safety · doi:10.2165/00002018-200831110-00009 · Cited by 21
Self-citationDifferences between males and females in risk of NSAID-related severe gastrointestinal events
Neutel, C. I., Maxwell, C. J., & Appel, W. C. (1999) · Pharmacoepidemiology and Drug Safety · doi:10.1002/(sici)1099-1557(199912)8:7<535::aid-pds456>3.0.co;2-d · Cited by 12
Violation of Homogeneity: A Methodologic Issue in the Use of Data Mining Tools
Lilienfeld, D. E., Nicholas, S., MacNeil, D. J., et al. (2003) · Drug Safety · doi:10.2165/00002018-200326050-00005 · Cited by 11
Cited by
Dixon, S. J., Patel, D. N., Welsch, M., Skouta, R., Lee, E. D., Hayano, M., Thomas, A. G., Gleason, C. E., Tatonetti, N. P., Slusher, B. S., et al. (2014) · eLife · doi:10.7554/elife.02523 · Cited by 2,088
Data Mining of the Public Version of the FDA Adverse Event Reporting System
Sakaeda, T., Tamon, A., Kadoyama, K., & Okuno, Y. (2013) · International Journal of Medical Sciences · doi:10.7150/ijms.6048 · Cited by 1,048
Data-driven prediction of drug effects and interactions
Tatonetti, N. P., Ye, P. P., Daneshjou, R., & Altman, R. B. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003377 · Cited by 936
Alomar, M., Tawfiq, A. M., Hassan, N., & Palaian, S. (2020) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098620938595 · Cited by 272
Fusaroli, M., Salvo, F., Begaud, B., AlShammari, T. M., Bate, A., Battini, V., Brueckner, A., Candore, G., Carnovale, C., Crisafulli, S., et al. (2024) · Drug Safety · doi:10.1007/s40264-024-01421-9 · Cited by 270
Self-citation
Metadata
- Authors
- Bate, A., & Evans, S. J. W.
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2009-04-08
- Volume
- 18
- Issue
- 6
- Pages
- 427-436
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W2074289946
- Cited by
- 912
- References
- 55
- FWCI
- 31.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.